Andrew Millar
Impact in
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 7
- Peptidase Inhibition and Analysis 4
- Colorectal Cancer Treatments and Studies 2
- HER2/EGFR in Cancer Research 2
-
- Protease and Inhibitor Mechanisms 2
- Cancer Genomics and Diagnostics 1
- Cancer, Lipids, and Metabolism 1
- Co-authors
- Kevin Lynch (5 shared papers)Peter de Nully Brown (4 shared papers)Amy Berrington de González (2 shared papers)John Primrose (2 shared papers)John H. Malfetano (1 shared paper)John Nemunaitis (1 shared paper)Alexander S. Rosemurgy (1 shared paper)Henrik Rasmussen (1 shared paper)
- Journals
- Nature reviews. Cancer (1 paper)British Journal of Cancer (1 paper)British Journal of Clinical Pharmacology (1 paper)European Journal of Cancer (1 paper)European Journal of Gastroenterology & Hepatology (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Andrew Millar
9 papers receiving 468 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 271
- Oncology 304
- Immunology and Allergy 38
- Hematology 56
- Molecular Biology 185
Countries citing papers authored by Andrew Millar
This map shows the geographic impact of Andrew Millar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Millar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Millar more than expected).
Fields of papers citing papers by Andrew Millar
This network shows the impact of papers produced by Andrew Millar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Millar. The network helps show where Andrew Millar may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Millar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies. | 1998 | 174 |
| 2 | 1998 | 80 | |
| 3 | 1999 | 74 | |
| 4 | 2003 | 55 | |
| 5 | 1999 | 52 | |
| 6 | 2001 | 22 | |
| 7 | 1998 | 20 | |
| 8 | 1996 | 9 | |
| 9 | 2015 | 4 |
About Andrew Millar
Andrew Millar is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pharmacology and Pathology and Forensic Medicine, having authored 9 papers that have together received 490 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (4 papers), Colorectal Cancer Treatments and Studies (2 papers), Protease and Inhibitor Mechanisms (2 papers), HER2/EGFR in Cancer Research (2 papers), Cancer Genomics and Diagnostics (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Cancer, Lipids, and Metabolism (1 paper) and Drug-Induced Hepatotoxicity and Protection (1 paper). The work is most often cited by research in Cancer Research (271 citations), Oncology (304 citations), Immunology and Allergy (38 citations), Hematology (56 citations) and Molecular Biology (185 citations). Andrew Millar has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Kevin Lynch, Peter de Nully Brown, Amy Berrington de González, John Primrose, John H. Malfetano, John Nemunaitis, Alexander S. Rosemurgy, Henrik Rasmussen, Donna S. Cox and C. J. Poole. Their work appears in journals such as Nature reviews. Cancer, British Journal of Cancer, British Journal of Clinical Pharmacology, European Journal of Cancer and European Journal of Gastroenterology & Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.